Trial intelligence / Profile preview

ACTIVATE Trial: BCG Vaccination to Prevent Infections in the Elderly

2017-000596-87Phase 4Completed

Sponsor
Hellenic Institute for the Study of Sepsis
Start
Mar 2017
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of bcg vaccine in bacterial disease, mycoses, sponsored by Hellenic Institute for the Study of Sepsis. Started Mar 2017; status: completed.

02

Drugs

bcg vaccine
03

Conditions

bacterial diseasemycoses

Beyond the preview

Go deeper on 2017-000596-87.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-000596-87.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call